Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

150
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
150
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

228
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
228
Dose-Response Relationship: Potency and Efficacy01:22

Dose-Response Relationship: Potency and Efficacy

4.6K
The potency of a drug is the measure of its ability to produce a biological response and can be compared by looking at the half-maximum effective concentration or EC50 values of different drugs. A lower EC50 value indicates higher potency of the drug. In the dose–response curve of two antihypertensive drugs, candesartan and irbesartan, a significant difference is observed in their EC50 values. A lower EC50 value for candesartan indicates that it is more potent than irbesartan, as it...
4.6K
Methods of Documentation V: CBE01:23

Methods of Documentation V: CBE

933
Charting by Exception, or CBE, is a method of documentation used in healthcare, particularly in nursing, that focuses on documenting only significant or abnormal findings rather than recording every detail. This approach aims to streamline the documentation process, improve efficiency, and ensure that healthcare providers can quickly identify deviations from normalcy in patient assessments.
In CBE, healthcare professionals establish predefined standards of practice that define what constitutes...
933
Hazard Ratio01:12

Hazard Ratio

168
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
168
Decision Making: P-value Method01:09

Decision Making: P-value Method

5.5K
The process of hypothesis testing based on the P-value method includes calculating the P- value using the sample data and interpreting it.
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim  is also stated. These statements can act as null and alternative hypotheses:  a null hypothesis would be a neutral statement while the alternative hypothesis can...
5.5K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Letter: Optimizing Endoscopic Approaches for Sphenoid Lateral Recess Cerebrospinal Fluid Leaks: Proposal of a New Algorithm.

Operative neurosurgery (Hagerstown, Md.)·2026
Same author

Clinical Implementation of AI for Pulmonary Embolism Detection in over 30 000 CT Pulmonary Angiography Examinations.

Radiology. Artificial intelligence·2026
Same author

Boron Neutron Capture Therapy for High-Grade CNS Tumors: Mechanisms, Carriers, and Clinical Progress: A Narrative Review.

International journal of molecular sciences·2026
Same author

Remarkable response to radiation in a non-enhancing diffuse pediatric-type high-grade glioma with germline <i>ATM</i> mutation: The role of PET imaging and integrated histological and molecular analysis.

Neuro-oncology advances·2026
Same author

<sup>68</sup>GA DOTATATE PET in Schwannomas: Distinct Avidity Pattern Supporting Noninvasive Diagnosis.

AJNR. American journal of neuroradiology·2026
Same author

Long-term outcomes of active surveillance after DOTATATE PET/MRI-confirmed gross total resection in WHO grade 2 meningioma.

Neuro-oncology advances·2026
Same journal

CT-Guided Epidural Blood Patch for Postoperative Lumbar Cerebrospinal Fluid Leak: A Case Series and Clinical Outcomes.

AJNR. American journal of neuroradiology·2026
Same journal

Clinical Outcomes of Isolated Subarachnoid Hemorrhage after Mechanical Thrombectomy.

AJNR. American journal of neuroradiology·2026
Same journal

Validation of an Automated ASPECTS Software via a Multi-Reader Multi-Case Clinical Reader Study.

AJNR. American journal of neuroradiology·2026
Same journal

Gender Trends in Authorship Across Neuroradiology Journals (2016-2025).

AJNR. American journal of neuroradiology·2026
Same journal

Outcomes of Endovascular Treatment in Large Vessel Occlusions Due to Intracranial Atherosclerotic Disease: A Systematic Review and Updated Meta-Analysis of 11,326 Patients.

AJNR. American journal of neuroradiology·2026
Same journal

Quantitative Impact of T1 Subtraction Maps on Enhancing Component Delineation and Measured Volumes in Minimally Enhancing Pediatric Brain Tumors.

AJNR. American journal of neuroradiology·2026
查看所有相关文章

相关实验视频

Updated: Jul 27, 2025

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
07:05

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents

Published on: September 10, 2018

6.0K

对成本效益分析的成本效益分析.

J Rodriguez1, G Martinez2,3, S Mahase4

  • 1From the Department of Radiology (J.R., M.R., A.H., S.K., G. Madera, J.R.O., E.L., J.I.).

AJNR. American journal of neuroradiology
|June 8, 2023
PubMed
概括
此摘要是机器生成的。

68Ga-DOTATATE PET/MR成像改善了接受放射治疗的脑膜瘤患者的质量调整寿命 (QALY). 这种先进的成像技术在术后规划中具有成本效益,与传统的MRI成像技术相比,它具有显著的优势.

更多相关视频

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

462
E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

8.4K

相关实验视频

Last Updated: Jul 27, 2025

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents
07:05

Operant Protocols for Assessing the Cost-benefit Analysis During Reinforced Decision Making by Rodents

Published on: September 10, 2018

6.0K
Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
06:16

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease

Published on: August 9, 2024

462
E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
06:28

E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy

Published on: August 1, 2019

8.4K

科学领域:

  • 放射学和核医学 放射学和核医学
  • 在瘤学瘤学.
  • 医学成像分析 医学成像分析

背景情况:

  • 增强对比度的MRI成像是诊断脑膜瘤和治疗评估的标准.
  • 68Ga-DOTATATE PET/MR成像显示在脑膜瘤管理和术后辐射规划方面具有前景.
  • 较高的感知成本限制了68Ga-DOTATATE PET/MR成像的临床实施.

研究的目的:

  • 分析68Ga-DOTATATE PET/MR成像用于中等风险脑膜瘤患者的切割后放射治疗计划的成本效益.
  • 在这种情况下,要比较68Ga-DOTATATE PET/MR成像与单独MR成像的实用性.

主要方法:

  • 制定一个结合指导方针和机构经验的决策分析模型.
  • 使用马尔科夫模型来估计经质量调整的寿命年 (QALY).
  • 从社会角度分析成本效益分析,支付意愿的门为5万美元/QALY和10万美元/QALY.
  • 基于已发表的文献验证模型结果的灵敏度分析.

主要成果:

  • 与单独的MRI成像相比,68Ga-DOTATATE PET/MR成像的结果是更高的QALY (5.47对5.05) 与增加的成本 ($404,260对$395,535) 相比.
  • 增量成本效益比率分析证实了在5万美元/QALY和10万美元/QALY的支付意愿门上的成本效益.
  • 灵敏度分析表明68Ga-DOTATATE PET/MR成像的成本效益在相应的门上具有特异性>76% (58%) 和灵敏度>53% (44%).

结论:

  • 68Ga-DOTATATE PET/MR成像是术后脑膜瘤治疗计划的经济有效补充.
  • 该研究表明,这种成像技术的成本效益高的灵敏度和特异性值在临床实践中是可以实现的.